I-Mab logo
I-Mab IMAB

Quarterly report 2025-Q2
added 03-21-2026

report update icon

I-Mab Net Income 2011-2026 | IMAB

Net profit is a financial indicator that reflects the remaining amount of money after deducting all expenses and taxes from the company’s total income over a certain period of time. It is one of the key indicators of a company’s financial stability and success.

Net profit is the portion of total profit remaining after taxes and depreciation have been deducted.[1]

It is the result of a company’s operations and reflects its efficiency in managing resources, controlling expenses, and generating income. It includes all operating revenues and expenses, such as sales of goods or services, production costs, administrative expenses, taxes, and other financial metrics.

The calculation of net profit includes the deduction of all necessary expenses such as employee salaries, rent, utilities, taxes, and other mandatory payments. After all these expenses are deducted from the total income, the remaining amount is considered the company’s net profit.

Net profit is an important indicator of a company’s financial health, as it reflects its ability to generate earnings and manage its finances. High net profit indicates business success, competitiveness, and efficiency in resource utilization. It also allows a company to invest in its development, pay dividends to shareholders, or create reserve funds for unforeseen situations.

It serves as a basis for calculating other financial indicators, such as return on sales, return on assets, or return on equity. It is also used to assess the performance of management and make decisions regarding the future development of the company.

However, it should be noted that net profit can be affected by various factors, such as economic conditions, changes in legislation, market competition, and other external influences. Therefore, companies must be prepared for possible changes and take measures to ensure the stability of their financial results.

Annual Net Income I-Mab

2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
- -1.47 B -2.51 B -2.33 B 471 M -1.45 B -403 M -298 M - - - - - -

All numbers in CNY currency

Indicator range from annual reports

Maximum Minimum Average
471 M -2.51 B -1.14 B

References

  1. Bhamornsiri, S., & Wiggins, C. (2001). Comprehensive income disclosures. The CPA Journal, 71(10), 54.

Net Income of other stocks in the Biotechnology industry

Issuer Net Income Price % 24h Market Cap Country
MorphoSys AG MorphoSys AG
MOR
-514 M - 2.43 % $ 254 M germanyGermany
Acorda Therapeutics Acorda Therapeutics
ACOR
-253 M - -24.86 % $ 820 K usaUSA
AbbVie AbbVie
ABBV
1.82 B $ 208.84 -2.86 % $ 369 B usaUSA
AbCellera Biologics AbCellera Biologics
ABCL
-146 M $ 3.52 0.28 % $ 1.05 B canadaCanada
Grifols, S.A. Grifols, S.A.
GRFS
265 M $ 8.24 -0.12 % $ 6.83 B spainSpain
Ascendis Pharma A/S Ascendis Pharma A/S
ASND
-384 M $ 229.25 0.44 % $ 5 B danmarkDanmark
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
603 M - - $ 40.3 B usaUSA
Genfit SA Genfit SA
GNFT
67.3 M - 2.54 % $ 160 B franceFrance
Biophytis SA Biophytis SA
BPTS
-31.2 M - -13.47 % $ 169 M franceFrance
Aeterna Zentaris Aeterna Zentaris
AEZS
-8.37 M - 5.93 % $ 314 M canadaCanada
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
-155 M - - $ 1.01 B usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
-18.4 M - - $ 26.5 M usaUSA
Akero Therapeutics Akero Therapeutics
AKRO
-252 M - - $ 3.67 B usaUSA
Midatech Pharma plc Midatech Pharma plc
MTP
-5.46 M - -18.52 % $ 27.3 M britainBritain
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
-8.09 M - -1.52 % $ 24.7 M usaUSA
ANI Pharmaceuticals ANI Pharmaceuticals
ANIP
-18.5 M $ 74.21 -2.3 % $ 1.43 B usaUSA
Adverum Biotechnologies Adverum Biotechnologies
ADVM
-131 M - - $ 86.2 M usaUSA
Advaxis Advaxis
ADXS
-48.1 M - -9.65 % $ 45.9 M usaUSA
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
-288 M $ 1.41 2.17 % $ 375 M britainBritain
AgeX Therapeutics AgeX Therapeutics
AGE
-19.2 M - -10.17 % $ 12.2 K usaUSA
Cocrystal Pharma Cocrystal Pharma
COCP
-8.83 M $ 1.51 48.04 % $ 17 M usaUSA
Applied Molecular Transport Applied Molecular Transport
AMTI
-126 M - - $ 10.1 M usaUSA
AIkido Pharma AIkido Pharma
AIKI
-22.4 M - 1.93 % $ 17.4 M usaUSA
Akouos Akouos
AKUS
-86.7 M - 0.23 % $ 488 M usaUSA
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
72.9 M - - - russiaRussia
Allena Pharmaceuticals Allena Pharmaceuticals
ALNA
-48.7 M - 3.16 % $ 1.9 M usaUSA
BioMarin Pharmaceutical BioMarin Pharmaceutical
BMRN
349 M $ 55.5 -3.04 % $ 10.6 B usaUSA
Alpine Immune Sciences Alpine Immune Sciences
ALPN
-57.8 M - - $ 2.17 B usaUSA
Aileron Therapeutics Aileron Therapeutics
ALRN
-49.9 M - 10.36 % $ 9.8 M usaUSA
Arcturus Therapeutics Holdings Arcturus Therapeutics Holdings
ARCT
-65.8 M $ 8.03 2.29 % $ 220 M israelIsrael
Adaptive Biotechnologies Corporation Adaptive Biotechnologies Corporation
ADPT
-59.5 M $ 14.81 2.63 % $ 2.25 B usaUSA
Altimmune Altimmune
ALT
-88.1 M $ 3.34 7.05 % $ 294 M usaUSA
BioNTech SE BioNTech SE
BNTX
10.3 B $ 91.18 1.97 % $ 27.2 B germanyGermany
Amgen Amgen
AMGN
7.71 B $ 347.94 -1.51 % $ 187 B usaUSA
Aurinia Pharmaceuticals Aurinia Pharmaceuticals
AUPH
211 M $ 15.61 0.9 % $ 2.1 B canadaCanada
Bristol-Myers Squibb Company Bristol-Myers Squibb Company
BMY
7.05 B $ 59.6 -2.45 % $ 121 B usaUSA
Aptose Biosciences Aptose Biosciences
APTO
-25.5 M - -45.71 % $ 1.2 M canadaCanada
Aptinyx Aptinyx
APTX
-64.8 M - -39.0 % $ 4.57 M usaUSA
CureVac N.V. CureVac N.V.
CVAC
-412 M - - $ 867 M germanyGermany
Burford Capital Limited Burford Capital Limited
BUR
172 M $ 4.14 -2.59 % $ 683 M britainBritain
BioCryst Pharmaceuticals BioCryst Pharmaceuticals
BCRX
-88.9 M $ 9.02 -3.84 % $ 1.86 B usaUSA
Avenue Therapeutics Avenue Therapeutics
ATXI
-2.91 M - -52.27 % $ 4.45 M usaUSA
Atea Pharmaceuticals Atea Pharmaceuticals
AVIR
-158 M $ 5.76 1.95 % $ 469 M usaUSA
BeiGene, Ltd. BeiGene, Ltd.
BGNE
287 M - 0.49 % $ 251 B cayman-islandsCayman-islands
AVROBIO AVROBIO
AVRO
12.2 M - 1083.1 % $ 745 M usaUSA
Cellectis S.A. Cellectis S.A.
CLLS
-125 M $ 3.41 1.19 % $ 116 M franceFrance
Biogen Biogen
BIIB
1.29 B $ 177.34 -3.5 % $ 26 B usaUSA
Axcella Health Axcella Health
AXLA
-81.2 M - -16.42 % $ 249 M usaUSA
Axon Enterprise Axon Enterprise
AXON
377 M $ 412.81 -2.54 % $ 31.3 B usaUSA